Skip to main content
Equibles
EVH logo

EVH

Evolent Health, Inc.
$5.88 +0.25 (+4.44%) At close · Jul 10
Market Cap
$661.39M
Shares
112,481,067

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.88 Open$5.67 Day$5.67–6.02 52W$2.10–11.81 Avg vol 30d2.3M Short int15.8M · 14.1% float · 5.9d Short vol62% Last earningsMay 7, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 7
Up next
Next earnings call
Aug 6, 2026 Est · unconfirmed · in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 7, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very High
      Market backdrop VIX 15 · calm Equity put/call 0.55
      Technical
      price trend
      Strong Buy
      50 / 200-day cross Golden cross
      Price vs 200-day avg +34%
      above
      Price vs 50-day avg +31%
      above
      RSI (14) 68
      neutral
      MACD trend Positive
      52-week position 39%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +32%
      trailing
      6-month return +49%
      trailing
      YTD return +47%
      this year
      Relative strength +40%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) Golden cross
      50d $4 › 200d $4 — 50d above 200d
      Institutional flow Distributing
      10 of 191 funds reported for Jun 30 · net -5.5K sh shares · +2 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      14.07% of float · ▲ +8.6% MoM · 5.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      191 holders — near 3-yr low, contrarian setup
      Squeeze score 79
      high risk · 0–100
      Fundamentals
      Weak
      Revenue growth −2%
      Y/Y
      EPS growth −526%
      Y/Y
      Free cash flow $3.3M
      Balance sheet $141.8M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 77%
      annualized · 1-yr
      Max drawdown −81%
      past year
      ATR 6.0%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record
      Latest guidance · from the 8-K filed May 7, 2026
      Full Year 2026
      Revenue Maintained $2.4B – $2.6B
      prior FY $1.88B midpoint +33.2% Y/Y
      Adjusted EBITDA Non-GAAP Maintained $110M – $140M
      2026
      Capitalized software development Initiated $25M – $30M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      0 · 3 · 4
      50 / 200-day cross
      Golden cross Bullish
      Price vs 200-day avg
      +34% Bullish
      Price vs 50-day avg
      +31% Bullish
      RSI (14)
      68 Neutral
      MACD trend
      Positive Bullish
      52-week position
      39% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) Golden cross
      50d $4 › 200d $4 — 50d above 200d
      Institutional flow Distributing
      10 of 191 funds reported for Jun 30 · net -5.5K sh shares · +2 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      14.07% of float · ▲ +8.6% MoM · 5.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      191 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      52-wk low $2 Now $6 · 39% 52-wk high $12
      vs 200-day avg +34% vs 50-day avg +31% 50-day above 200-day golden cross

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Average Lives on Platform/Cases - Administrative Services 1,118 Three Months Ended March 31, 2026 —
      Average Lives on Platform/Cases - Cases 11 Three Months Ended March 31, 2026 —
      Average Lives on Platform/Cases - Performance Suite 6,078 Three Months Ended March 31, 2026 —
      Average Lives on Platform/Cases - Specialty Technology and Services Suite 76,101 Three Months Ended March 31, 2026 —
      Average PMPM Fee - Administrative Services $14.78 Three Months Ended March 31, 2026 —
      Average PMPM Fee - Performance Suite $17.73 Three Months Ended March 31, 2026 —
      Average PMPM Fee - Specialty Technology and Services Suite $0.35 Three Months Ended March 31, 2026 —
      Average Revenue per Case $3,772 Three Months Ended March 31, 2026 —
      Average Unique Members 38,903 Three Months Ended March 31, 2026 —
      Adjusted EBITDA non-GAAP $37,793K Q4 2025 —
      Administrative Services Average Lives on Platform 1,218 Q4 2025 —
      Administrative Services Average PMPM Fees $15.27 Q4 2025 —
      Cases 14 Q4 2025 —
      Cases Revenue per Case $3,537 Q4 2025 —
      Medical Expense Ratio excluding Evolent Care Partners 94.8% Q4 2025 —
      Performance Suite Average Lives on Platform 6,475 Q4 2025 —
      Performance Suite Average PMPM Fees $13.87 Q4 2025 —
      Specialty Technology and Services Suite Average Lives on Platform 79,677 Q4 2025 —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      EVH
      Evolent Health, Inc.
      this stock
      		$661.39M +47.0% -1.8% — 14.1%
      VEEV
      Veeva Systems Inc
      		 $30.88B -14.8% +28.1% 33.7 4.6%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $15.67B -9.4% — — 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      		 $13.85B +90.7% -0.4% 51.0 6.6%
      TEM
      Tempus AI, Inc.
      		 $10.46B -1.4% +65.8% — 18.7%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      192
      % held
      97.6%
      Reported
      10 of 191
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      151
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      15.8M
      Days to cover
      5.9d
      Change
      +1.2M sh
      View
      Short Volume
      Short vol %
      62%
      As of
      Jul 10, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2.5K
      Value
      $11.8K
      As of
      Jun 10, 2026
      View
      Off-Exchange
      Off-exchange %
      37.1%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Greg Gianforte
      Amount
      $50.0K–$100.0K
      Traded
      May 11, 2020
      View
      Financials
      Financials
      Revenue (FY)
      $1.9B
      Net income (FY)
      $-534.5M
      EPS diluted
      $-5.07
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 4, 2026
      This year
      6
      View
      Proposed Sales
      Value
      $93.9K
      Shares
      9.2K
      Filed
      Feb 25, 2025
      View
      Exempt Offerings
      Offering
      $728.0K
      Filed
      May 26, 2023
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 7, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      EVH +3.0% +31.5% +49.2% +8.5% +47.0%
      SPY +1.4% +4.1% +9.1% +1.1% +10.7%
      vs SPY +1.6% +27.5% +40.2% +7.4% +36.3%
      Key facts CIK 1628908 CUSIP 30050B101 13F (30d) 11 filings 10 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)